{"pmid":32454505,"title":"Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study.","text":["Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study.","Nephron","Sun, Dan-Qin","Wang, Ting-Yao","Zheng, Kenneth I","Targher, Giovanni","Byrne, Christopher D","Chen, Yong-Ping","Zheng, Ming-Hua","32454505"],"journal":"Nephron","authors":["Sun, Dan-Qin","Wang, Ting-Yao","Zheng, Kenneth I","Targher, Giovanni","Byrne, Christopher D","Chen, Yong-Ping","Zheng, Ming-Hua"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454505","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1159/000508502","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667881798432980992,"score":9.490897,"similar":[{"pmid":32416116,"title":"ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19.","text":["ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19.","The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis.","Kidney Int","Hirsch, Jamie S","Ng, Jia H","Ross, Daniel W","Sharma, Purva","Shah, Hitesh H","Barnett, Richard L","Hazzan, Azzour D","Fishbane, Steven","Jhaveri, Kenar D","32416116"],"abstract":["The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis."],"journal":"Kidney Int","authors":["Hirsch, Jamie S","Ng, Jia H","Ross, Daniel W","Sharma, Purva","Shah, Hitesh H","Barnett, Richard L","Hazzan, Azzour D","Fishbane, Steven","Jhaveri, Kenar D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416116","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.kint.2020.05.006","keywords":["aki","covid-19","crrt","dialysis","renal failure"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666994545963827200,"score":48.303043},{"pmid":32299479,"pmcid":"PMC7161433","title":"Acute kidney injury in SARS-CoV-2 infected patients.","text":["Acute kidney injury in SARS-CoV-2 infected patients.","Crit Care","Fanelli, Vito","Fiorentino, Marco","Cantaluppi, Vincenzo","Gesualdo, Loreto","Stallone, Giovanni","Ronco, Claudio","Castellano, Giuseppe","32299479"],"journal":"Crit Care","authors":["Fanelli, Vito","Fiorentino, Marco","Cantaluppi, Vincenzo","Gesualdo, Loreto","Stallone, Giovanni","Ronco, Claudio","Castellano, Giuseppe"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299479","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1186/s13054-020-02872-z","link_comment_for":"32204722","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138494886477825,"score":46.518303},{"pmid":32503180,"title":"Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.","text":["Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.","The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined according to the Acute Kidney Injury Network. Of the 164 hospitalized patients with COVID-19, 30 patients (18.3%) had AKI; 14, 4, and 12 patients had stage 1, 2, and 3, respectively. The median age was significantly higher in AKI patients than in non-AKI patients (75.5 vs. 67.0 years, p = 0.005). There were 17 deaths (56.7%) among AKI patients; 4 (28.6%), 1 (25.0%), and 12 (100.0%), respectively. In-hospital mortality was higher in AKI patients than in non-AKI patients (56.7% vs. 20.8%, p < 0.001). After adjusting for potential confounding factors, stage 3 AKI was associated with higher mortality than either non-AKI or stage 1 AKI (hazard ratio (HR) = 3.62 (95% confidence interval (CI) = 1.75-7.48), p = 0.001; HR = 15.65 (95% CI = 2.43-100.64), p = 0.004). Among the AKI patients, acute respiratory distress syndrome and low serum albumin on admission were considered independent risk factors for stage 3 AKI (both p < 0.05). Five patients with stage 3 AKI underwent dialysis and eventually died. In conclusion, COVID-19 patients with severe AKI had fatal outcomes.","J Clin Med","Lim, Jeong-Hoon","Park, Sun-Hee","Jeon, Yena","Cho, Jang-Hee","Jung, Hee-Yeon","Choi, Ji-Young","Kim, Chan-Duck","Lee, Yong-Hoon","Seo, Hyewon","Lee, Jaehee","Kwon, Ki Tae","Kim, Shin-Woo","Chang, Hyun-Ha","Kim, Yong-Lim","32503180"],"abstract":["The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined according to the Acute Kidney Injury Network. Of the 164 hospitalized patients with COVID-19, 30 patients (18.3%) had AKI; 14, 4, and 12 patients had stage 1, 2, and 3, respectively. The median age was significantly higher in AKI patients than in non-AKI patients (75.5 vs. 67.0 years, p = 0.005). There were 17 deaths (56.7%) among AKI patients; 4 (28.6%), 1 (25.0%), and 12 (100.0%), respectively. In-hospital mortality was higher in AKI patients than in non-AKI patients (56.7% vs. 20.8%, p < 0.001). After adjusting for potential confounding factors, stage 3 AKI was associated with higher mortality than either non-AKI or stage 1 AKI (hazard ratio (HR) = 3.62 (95% confidence interval (CI) = 1.75-7.48), p = 0.001; HR = 15.65 (95% CI = 2.43-100.64), p = 0.004). Among the AKI patients, acute respiratory distress syndrome and low serum albumin on admission were considered independent risk factors for stage 3 AKI (both p < 0.05). Five patients with stage 3 AKI underwent dialysis and eventually died. In conclusion, COVID-19 patients with severe AKI had fatal outcomes."],"journal":"J Clin Med","authors":["Lim, Jeong-Hoon","Park, Sun-Hee","Jeon, Yena","Cho, Jang-Hee","Jung, Hee-Yeon","Choi, Ji-Young","Kim, Chan-Duck","Lee, Yong-Hoon","Seo, Hyewon","Lee, Jaehee","Kwon, Ki Tae","Kim, Shin-Woo","Chang, Hyun-Ha","Kim, Yong-Lim"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503180","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3390/jcm9061718","keywords":["aki severity","covid-19","acute kidney injury","mortality","renal replacement therapy"],"locations":["Daegu","South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668892488337719296,"score":44.908405},{"pmid":32251568,"pmcid":"PMC7154984","title":"Covid-19 in South Korea - Challenges of Subclinical Manifestations.","text":["Covid-19 in South Korea - Challenges of Subclinical Manifestations.","N Engl J Med","Song, Joon-Young","Yun, Jin-Gu","Noh, Ji-Yun","Cheong, Hee-Jin","Kim, Woo-Joo","32251568"],"journal":"N Engl J Med","authors":["Song, Joon-Young","Yun, Jin-Gu","Noh, Ji-Yun","Cheong, Hee-Jin","Kim, Woo-Joo"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251568","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1056/NEJMc2001801","locations":["South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Diagnosis","Transmission","Prevention"],"weight":1,"_version_":1666138490963755009,"score":44.775517},{"pmid":32370577,"title":"Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.","text":["Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.","Background: To investigate the risk factors related to aggravation and clinical outcomes in coronavirus disease 2019 (COVID-19) patients.Methods: We performed a retrospective study on the risk factors for disease progression of cases with COVID-19. Based on the clinical types, the patients were divided into a progression group and an improvement group. Multivariable logistic regression and ROC curve analysis were performed to explore the risk factors for disease progression.Results: A total of 101 patients were included in this study; diseases progression occurred in 17 patients, 84 patients improved, 6 were transferred to intensive care unit (ICU), and 5 died. The mean time to obtain negative nucleic acid results was 12.5 +/- 5.0 days. Multivariate logistic analysis indicated that age (OR, 0.104; p = .002), C-reactive protein (CRP) (OR, 0.093; p < .001) and lymphocyte count (OR, 3.397; p = .022) were risk factors for disease progression. ROC curve analysis revealed that the AUC of age, CRP and lymphocyte count for disease progression were 0.873, 0.911 and 0.817, respectively.Conclusions: Older age increased CRP and decreased lymphocyte count resulted in potential risk factors for COVID-19 progression. This may be helpful in identifying patients whose condition worsens at an early stage.","Infect Dis (Lond)","Hou, Wei","Zhang, Wei","Jin, Ronghua","Liang, Lianchun","Xu, Bin","Hu, Zhongjie","32370577"],"abstract":["Background: To investigate the risk factors related to aggravation and clinical outcomes in coronavirus disease 2019 (COVID-19) patients.Methods: We performed a retrospective study on the risk factors for disease progression of cases with COVID-19. Based on the clinical types, the patients were divided into a progression group and an improvement group. Multivariable logistic regression and ROC curve analysis were performed to explore the risk factors for disease progression.Results: A total of 101 patients were included in this study; diseases progression occurred in 17 patients, 84 patients improved, 6 were transferred to intensive care unit (ICU), and 5 died. The mean time to obtain negative nucleic acid results was 12.5 +/- 5.0 days. Multivariate logistic analysis indicated that age (OR, 0.104; p = .002), C-reactive protein (CRP) (OR, 0.093; p < .001) and lymphocyte count (OR, 3.397; p = .022) were risk factors for disease progression. ROC curve analysis revealed that the AUC of age, CRP and lymphocyte count for disease progression were 0.873, 0.911 and 0.817, respectively.Conclusions: Older age increased CRP and decreased lymphocyte count resulted in potential risk factors for COVID-19 progression. This may be helpful in identifying patients whose condition worsens at an early stage."],"journal":"Infect Dis (Lond)","authors":["Hou, Wei","Zhang, Wei","Jin, Ronghua","Liang, Lianchun","Xu, Bin","Hu, Zhongjie"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32370577","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/23744235.2020.1759817","keywords":["covid-19","risk factors outcome"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496454098945,"score":44.50668}]}